Haopeng Q. Sun

639 Longmian Avenue
Nanjing, 211198, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 181 publications

Lanolin-derived bioactive fractions promote infected wound healing via synergistic anti-inflammatory and pro-survival effects.

Lanolin-derived bioactive fractions promote infected wound healing via synergistic anti-inflammatory and pro-survival effects.

Journal: Natural product research

Published: August 21, 2026

Design, Synthesis, and Biological Evaluation of a Cathepsin B-Activated Small Molecule-Drug Conjugate Targeting AKR1C3 to Enhance Chemotherapeutic Selectivity.

Design, Synthesis, and Biological Evaluation of a Cathepsin B-Activated Small Molecule-Drug Conjugate Targeting AKR1C3 to Enhance Chemotherapeutic Selectivity.

Journal: Journal of medicinal chemistry

Published: July 18, 2026

Development of potent BChE/Nrf2 modulators for Alzheimer's disease treatment via dual suppression of ferroptosis.

Development of potent BChE/Nrf2 modulators for Alzheimer's disease treatment via dual suppression of ferroptosis.

Journal: European journal of medicinal chemistry

Published: May 05, 2026

Current landscape and future perspectives of small-molecule therapeutics for Huntington's disease: From rational design to clinical translation.

Current landscape and future perspectives of small-molecule therapeutics for Huntington's disease: From rational design to clinical translation.

Journal: European journal of medicinal chemistry

Published: April 17, 2026

FSP1, a key ferroptosis suppressor with therapeutic potential.

FSP1, a key ferroptosis suppressor with therapeutic potential.

Journal: Biochemical pharmacology

Published: March 23, 2026

Rewiring cell death and evading repair: Evolution of temozolomide and emerging strategies against resistant glioblastoma.

Rewiring cell death and evading repair: Evolution of temozolomide and emerging strategies against resistant glioblastoma.

Journal: European journal of medicinal chemistry

Published: March 22, 2026

Unlocking new frontiers in AKR1B10 inhibition and future opportunities.

Unlocking new frontiers in AKR1B10 inhibition and future opportunities.

Journal: European journal of medicinal chemistry

Published: March 19, 2026

PROTACs for central nervous system disorders: challenges and opportunities.

PROTACs for central nervous system disorders: challenges and opportunities.

Journal: Bioorganic & medicinal chemistry

Published: February 16, 2026

Development of tacrine-based multitarget-directed ligands as dual AChE/EGFR inhibitors with neuroprotective activity.

Development of tacrine-based multitarget-directed ligands as dual AChE/EGFR inhibitors with neuroprotective activity.

Journal: Bioorganic & medicinal chemistry

Published: February 10, 2026

Target-driven machine learning-enabled virtual screening (TAME-VS) enables prioritization of AKR1C3 inhibitors.

Target-driven machine learning-enabled virtual screening (TAME-VS) enables prioritization of AKR1C3 inhibitors.

Journal: Communications chemistry

Published: February 05, 2026

Discovery of Highly Selective AKR1C3 Inhibitors to Overcome EGFR C797S-Mediated Osimertinib Resistance in Non-Small Cell Lung Cancer.

Discovery of Highly Selective AKR1C3 Inhibitors to Overcome EGFR C797S-Mediated Osimertinib Resistance in Non-Small Cell Lung Cancer.

Journal: Journal of medicinal chemistry

Published: January 30, 2026

AKR1C3 Binds β-Trcp to Promote the Degradation of TFRC to Protect Hepatocellular Carcinoma From Ferroptosis.

AKR1C3 Binds β-Trcp to Promote the Degradation of TFRC to Protect Hepatocellular Carcinoma From Ferroptosis.

Journal: Cancer science

Published: January 30, 2026

Showing 1-12 of 181

Last Updated: 09/26/2026